UCL spin-out Domainex raises £1 million
Domainex, a biopharmaceutical spin-out from University College London (UCL), has raised £1 million to develop its contract research business and commercialise its drug discovery projects.
News
Domainex, a biopharmaceutical spin-out from University College London (UCL), has raised £1 million to develop its contract research business and commercialise its drug discovery projects.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software